Skip to content

CorMedix CRMD Total Revenue

Discontinued — last reported Q1 '26

Total Revenue at other companies

Pfizer logo
PfizerPFE
$14.45B+5.4%
Merck & Co. logo
Merck & Co.MRK
$16.29B+4.9%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$381.88M+7.5%
ITG
Integer HoldingsITGR
$439.58M+0.5%
IAR
Integra LifeSciencesIART
$391.92M+2.4%
MiMedx Group logo
MiMedx GroupMDXG
$58.99M-33.1%

Segments

By product

See full
DefenCath$97.51M+150%
Melinta Portfolio$24.41M
Contract revenue$5.51M

Other financials

Income statement

See full
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's total revenue?
CorMedix (CRMD) reported total revenue of $127.43M in Q1 2026.
How has CorMedix's total revenue changed year-over-year?
CorMedix's total revenue increased by 226.1% year-over-year, from $39.08M to $127.43M.
What is the long-term trend for CorMedix's total revenue?
Over 3 years (2021 to 2025), CorMedix's total revenue has grown at a 1077.5% compound annual growth rate (CAGR), from $190.94K to $311.71M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.